首页> 外国专利> Probucol-based amorphous pharmaceutical substance, physically stable in the conditions of compression and after compression, and method for obtaining it

Probucol-based amorphous pharmaceutical substance, physically stable in the conditions of compression and after compression, and method for obtaining it

机译:在压制条件下和压制后在物理上稳定的基于丙丁酚的无定形药物及其制备方法

摘要

the object of the application is amorphous pharmaceutical substance based on probukolu, physically stable under compression and after compression, and the way of obtaining.the substance is the double amorphous system two medicines, it is probukolu of model 1 and model 2 of atorvastatin and atorvastatin in share system is at least 9%.the application also includes a way, which is that crystalline pharmaceutical substances in the form of probukolu (4,4 '- [propane - 2,2 - diylbis (thio)] bis (2,6 - di - tert - butylphenolu)) of model 1 and atorvastatin (acid (3r, 5r) - 7 - [2 - (4-fluorophenyl) - 3 - 4 - phenyl - (phenylcarbamoyl) - 5 - propane - 2 - ylopirol - 1 - yl] - 3.5 dihydroksyheptanowego) of model 2, connection,until obtaining a homogeneous mixture, the proportions are chosen to mixture contains at least 9% atorvastatin, subsequently the mixture at a temperature from 125 to merges 150u00b0c,until a full meltdown and a transparent liquid, after which przechu0142adza with cooling speed not slower than 5u00b0c / min,to achieve the temperature below the transition temperature of the vitreous.
机译:本申请的目的是基于普罗布科卢的无定形药物,其在压缩和压缩后的物理稳定性以及获得的方式。该物质是双重无定形系统的两种药物,是阿托伐他汀和阿托伐他汀的模型1和模型2的普罗布科卢。份额至少为9%。该申请还包括一种方式,即以Pro​​bukolu(4,4'-[丙烷-2,2-二基双(硫代)] bis(2,6 -1型和阿托伐他汀(酸(3r,5r)-7-[2--(4-氟苯基)-3-4-苯基-(苯基氨基甲酰基)-5-丙烷-2-吡咯洛尔- 1-yl]-3.5的模型2的连接,直到获得均质混合物,选择比例的混合物中至少含有9%的阿托伐他汀,随后该混合物在125至150的温度下合并至150 u00b0c,直至完全融化并形成透明液体,然后在冷却下进行速度不低于5℃/ min,以达到低于玻璃体转变温度的温度。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号